"Not that I can't think of some good examples of RS failures, but they simply do not have the holy grail of anything."
Based on my experience, there is one bad example and one good example:
HEB/AIM. I own few thousand of shares before this company reverse-split twice and now I own paltry of 10 shares. This company has products, but mostly performing clinical trials and research. They are having difficulties getting FDA approvals. This stock got very hot several months ago for having a potential vaccine for the virus and then the flame died out after realizing that their products didn't do very well against the virus. Bottom line, they have the products, but reverse-splitting couple of times hurting the shareholders.
ARNA. This company was one of few that produces pills that makes you full for dieting purposes (BELVIQ). The sales of these pills fall flat for some reasons, even though BELVIQ was approved by the FDA. The unexpected lower sales from the diet pills forced the company to perform the reverse split. Sometimes later, the company started to produce other drugs and started to build up their own drug pipelines. This makes their stock price to go up nicely. I didn't own much shares due to reverse split, but I am in the profit range.
As for KBLB, I do agree with certain posters that Kim should sell some of the spider silks and get some consistent earnings before going to NASDAQ. I do feel that Kim is rushing and it may backfire the company. Get the sales and contracts and get the stock appreciation first, before leapfrogging to NASDAQ. Reverse-splitting the stock just to make a quick transfer to another exchange is never a good idea regardless. Spider silks are in no doubt the most disruptive technology we ever face and let's not ruin that moment and that opportunity. Sell them first, then we celebrate
